These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 6388105)
21. OKT3 escalating dose regimens provide effective therapy for renal allograft rejection. Woodle ES; Bruce DS; Josephson M; Cronin D; Newell KA; Millis JM; Piper JB; O'Laughlin R; Thistlethwaite JR Clin Transplant; 1996 Aug; 10(4):389-95. PubMed ID: 8884115 [TBL] [Abstract][Full Text] [Related]
22. Specific immunosuppression of corneal allograft rejection by combination of anti-VLA-4 and anti-LFA-1 monoclonal antibodies in mice. Hori J; Isobe M; Yamagami S; Mizuochi T; Tsuru T Exp Eye Res; 1997 Jul; 65(1):89-98. PubMed ID: 9237869 [TBL] [Abstract][Full Text] [Related]
23. Functional assessment of immune markers of graft rejection: a comprehensive study in live-related donor renal transplantation. Panigrahi A; Deka R; Bhowmik D; Dash SC; Tiwari SC; Guleria S; Mehta SN; Mehra NK Clin Transplant; 2006; 20(1):85-90. PubMed ID: 16556160 [TBL] [Abstract][Full Text] [Related]
24. The use of OKT3 to treat steroid-resistant renal allograft rejection in patients receiving cyclosporine. Thistlethwaite JR; Haag BW; Gaber AO; Stuart JK; Aronson AJ; Mayes JT; Lloyd DM; Stuart FP Transplant Proc; 1987 Feb; 19(1 Pt 3):1901-4. PubMed ID: 3103294 [No Abstract] [Full Text] [Related]
25. Human renal allograft and peripheral blood T lymphocyte subpopulations during the onset and treatment of rejection. Taube D; Welsh K; Hobby P; Williams DG Clin Nephrol; 1984 Sep; 22(3):127-32. PubMed ID: 6237816 [TBL] [Abstract][Full Text] [Related]
26. Immunoexpression of perforin and granzyme B on infiltrating lymphocytes in human renal acute allograft rejection. Wagrowska-Danilewicz M; Danilewicz M Nefrologia; 2003; 23(6):538-44. PubMed ID: 15002789 [TBL] [Abstract][Full Text] [Related]
27. Treatment of acute cellular kidney allograft rejection with T10B9.1A-31A anti T-cell monoclonal antibody. Waid TH; Lucas BA; Thompson JS; Brown S; Moore D; Amlot P; Janossy G Transplant Proc; 1989 Feb; 21(1 Pt 2):1778-84. PubMed ID: 2652582 [No Abstract] [Full Text] [Related]
28. Effectivity of a T-cell-adapted induction therapy with anti-thymocyte globulin (Sangstat). Koch A; Daniel V; Dengler TJ; Schnabel PA; Hagl S; Sack FU J Heart Lung Transplant; 2005 Jun; 24(6):708-13. PubMed ID: 15949731 [TBL] [Abstract][Full Text] [Related]
29. E-rosette forming cell numbers in the blood of human renal allograft recipients. Kelly GE; Sheil AG Clin Exp Immunol; 1977 Mar; 27(3):454-63. PubMed ID: 324670 [TBL] [Abstract][Full Text] [Related]
30. Late acute rejection in long-term renal allograft recipients. Diagnostic and predictive value of circulating activated T cells. Reinke P; Fietze E; Döcke WD; Kern F; Ewert R; Volk HD Transplantation; 1994 Jul; 58(1):35-41. PubMed ID: 7913561 [TBL] [Abstract][Full Text] [Related]
31. Blood group Lewis alloantibodies cause antibody-mediated rejection in renal transplant recipients. Boratyńska M; Banasik M; Hałoń A; Patrzałek D; Klinger M Transplant Proc; 2007 Nov; 39(9):2711-4. PubMed ID: 18021965 [TBL] [Abstract][Full Text] [Related]
32. Inhibition of chronic rejection and development of tolerogenic T cells after ICOS-ICOSL and CD40-CD40L co-stimulation blockade. Guillonneau C; Aubry V; Renaudin K; Séveno C; Usal C; Tezuka K; Anegon I Transplantation; 2005 Aug; 80(4):546-54. PubMed ID: 16220623 [TBL] [Abstract][Full Text] [Related]
34. Overview of the development of Orthoclone OKT3: monoclonal antibody for therapeutic use in transplantation. Goldstein G Transplant Proc; 1987 Apr; 19(2 Suppl 1):1-6. PubMed ID: 3105134 [No Abstract] [Full Text] [Related]
35. Immunosuppression with monoclonal antibodies. A model to determine the rules for effective serotherapy. Cobbold SP; Thierfelder S; Waldmann H Mol Biol Med; 1983 Oct; 1(3):285-304. PubMed ID: 6209527 [TBL] [Abstract][Full Text] [Related]